Introduction
Investigation of the natural product chemistry of blood cells of marine organisms known as ascidians over the years has led to the identification of a number of modified peptides bearing C-terminus decarboxy-enamide moieties. 1 These natural products, collectively known as tunichromes, typically incorporate either a decarboxy-(E)-α,β-dehydro-3,4-dihydroxyphenyl alanine (dcΔDOPA) or a decarboxy-(E)-α,β-dehydro-3,4,5-trihydroxyphenyl alanine (dcΔTOPA) residue at the C-terminus. 2 While no role has been ascribed with any confidence, potential ecological roles proposed for the tunichromes include iron or vanadium sequestration, cross-linking/tunic formation or as primitive wound repair or clotting agents. 3 Unusual members of the tunichrome-family are halocyamines A (1) and B, two DOPA-containing modified tetrapeptides, isolated from the ascidian Halocynthia roretzi (Fig. 1) . 4 NMR and mass spectrometry data were used to characterize the natural products, with acidic hydrolysis, labelling and HPLC analysis used to establish the configuration of the L-His and L-DOPA residues. The structures of the halocyamines were unusual additions to the tunichrome family of modified peptides in that they contained the rare Z-configuration 6-bromoindolic enamide moiety 5, 6 at the C-terminus. Biological evaluation of halocyamine A revealed a wide range of activities, including growth inhibition of Gram-positive bacteria, 4a Gramnegative marine bacteria and fish RNA viruses. 7 As part of our ongoing investigation of the synthesis and biological investigation of tunichromes, 8 we now report the synthesis and structural confirmation of halocyamine A (1) and present the results of preliminary biological evaluation.
Results and discussion
Prior to attempting the synthesis of halocyamine A, we chose to target the phenylenamide-containing model compound 2 (Fig. 2) . Established routes for the synthesis of enamides include dehydration 9 or elimination 10 methods, both of which favour the formation of the E-enamide product. In contrast, hydroamidation coupling of terminal alkynes with primary amides using a ruthenium complex/ytterbium triflate catalyst has been shown to give exclusively the Z-enamide product.
11 Thus we envisaged that 2 could be prepared by reaction of the appropriately protected tripeptide L-His-L-DOPA-Gly-NH 2 (3) with phenylacetylene (Scheme 1). Tripeptide 3 was prepared by standard Fmoc solid-phase peptide synthesis procedures using 2-chlorotrityl resin, protected amino acids Fmoc-His(Trt)-OH, Fmoc-DOPA(TBDMS) 2 -OH 12 and Fmoc-Gly with HATU as the coupling agent. Cleavage from the resin using 2,2,2-trifluoroethanol afforded the protected tripeptide carboxylic acid 4 in 79% yield over seven steps. Subsequent reaction of 4 with HOBt·NH 3 resulted in smooth conversion to the required tripeptide amide 3 (90% yield). Attempted hydroamidation of 3 and phenylacetylene using 5 mol% bis(2-methylallyl)(1,5-cyctooctadiene)ruthenium(II) heated at 60°C for 6 h failed to afford the expected enamide-containing product. Unexpectedly, the only products detected were 1,4-disubstituted enynes 5 and 6, isolated as a mixture in a ratio of 1 : 0.8 in 80% yield. Comparison with literature NMR data previously reported for 5 and 6 confirmed their identities. 13 Based on the outcome of this reaction, we speculated that the steric bulk of tripeptide-amide 3 resulted in crowding at the ruthenium catalytic centre, preventing the progress of the expected hydroamidation reaction.
We next explored an alternative route to model analogue 2: disconnection at the DOPA-Gly amide bond which would require dipeptide 7 and enamide 8 (Fig. 3) . Protected dipeptide Fmoc-His(Trt)-DOPA(TBDMS) 2 -OH 7 was prepared by SPPS, in a similar manner to that described for 4, in 85% yield over five steps.
The synthesis of styryl enamide 8 was achieved in two steps, whereby hydroamidation of Fmoc-glycinamide (9) with phenylacetylene gave protected enamide 10 (96% yield, based upon stoichiometry of 9), 14 which upon reaction with 20% piperidine/DMF gave 8 (84% yield) (Scheme 2). Alternatively, 8 could be prepared via hydroamidation of Boc-Gly-NH 2 (11) with phenylacetylene to give 12 (78% yield) which was deprotected cleanly in TFA/TIS/H 2 O (95 : 2.5 : 2.5) to give 8 (78% yield). With 7 and 8 in-hand, coupling using HBTU and HOBt in DMF gave 13 in 35% yield (Scheme 3). Stepwise deprotection of the N-terminus using piperidine/DMF (20 min) gave 14 (94% yield), followed by deprotection of the catechol group (triethylamine-trihydrogen fluoride, THF, 55 min) to give 15 (73% yield) and finally, removal of the trityl protecting group (0.01 N HCl/HFIP, 1 h) gave phenyl enamide model compound 2 as the dihydrochloride salt.
With the successful synthesis of phenylenamide model 2, we chose to employ a similar disconnection methodology for the synthesis of halocyamine A (1), requiring protected dipeptide L-His-L-DOPA (7) and glycyl-indolic enamide 16 (Scheme 4). We have recently demonstrated that the ruthenium catalysed hydroamidation methodology allows rapid synthetic entry to indolic Z-enamides by coupling an appropriately substituted indole-3-alkyne (i.e. 17) with a primary amide. 15 Scheme 1 Attempted synthesis of model enamide 2. Of note, a number of transition metals are known to promote alkyne dimerization, 18 including ruthenium, 19 though with somewhat variable regio-(head-to-head vs. head-to-tail) and stereoselectivity.
Removal of the Boc protecting group of enamide 21 using TFA/CH 2 Cl 2 afforded 16 in 80% yield. Peptide coupling (EDC, HOBt, DIPEA, 6 h) of enamide 16 and dipeptide acid 7 gave protected halocyamine A 23 in a disappointing yield of 18%. Efforts to increase the yield of this reaction by altering the coupling agent (HATU or HBTU), reaction time (9 h or 24 h), and the ratio of reactants 7/16 (2 : 1, 1 : 1 or 1 : 2) met with no success (data not shown). Sequential Fmoc deprotection ( piperidine, DMF, 20 min) gave 24 (75% yield), followed by desilylation (triethylamine trihydrofluoride, THF, 55 min) to give 25 (63% yield) and removal of the trityl group (HCl/HFIP, H 2 O, TIS, 1 h) gave the crude peptide that was purified by reversed-phase C 8 The original reports of the halocyamines noted their abilities to inhibit the growth of Gram-positive bacteria, Gramnegative marine bacteria and fish RNA viruses. 
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Escherichia coli ATCC 25922, Enterococcus faecalis ATCC 29212), and marine Gram-negative bacteria (Vibrio harveyi ATCC
Conclusions
In summary, we have described a total synthesis of the marine natural product halocyamine A (1), making use of a ruthenium-catalysed hydroamidation of an indole acetylene with Fmoc-glycinamide to form the critical Z-enamide moiety. The natural product exhibits only mild levels of antibacterial activity. The relative ease of synthesis of halocyamine A now opens the door for future investigation of the potential ecological roles played by this unusual member of the tunichrome family of marine natural products.
Experimental

General information and materials
Optical rotations were recorded using a 0.1 dm cell in methanol or dichloromethane. NMR spectra were recorded at either 500 or 400 MHz for 1 H nuclei and 125 or 100 MHz for 13 relative integral, multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet, br = broad, obs = obscured), coupling constant ( J, Hz), and the assignment of the atom. 13 C NMR data are reported as position (δ) and assignment of the atom. Assignments were based on 2D NMR data acquired using standard pulse sequences. (+)-ESI-MS data were acquired on a micrOTOF Q II mass spectrometer. Column chromatography was carried out with either C 8 reversed-phase or silica gel. All solvents used were distilled analytical grade or better. Chemical reagents were purchased from a commercial supplier and used without purification. 6-Bromo-3-iodo-indole 18 was prepared by a literature method. 16, 17 Fmoc-His(Trt)-DOPA(TBDMS) 2 -Gly-OH (4). Fmoc-glycine (0.595 g, 2.00 mmol) dissolved in CH 2 Cl 2 (15 mL) was added to 2-chlorotrityl chloride resin (loading 0.5 mmol g −1 , 4.00 g) followed by DIPEA (0.35 mL, 2.0 mmol). The mixture was agitated for 10 min and DIPEA (0.52 mL, 3.0 mmol) was added and the mixture was further shaken for 1 h. The solution was drained and the resin was washed with DMF (10 mL). A solution of CH 2 Cl 2 /MeOH/DIPEA (80 : 15 : 5, 25 mL) was added and the mixture agitated for 20 min. The solution was drained and the procedure repeated. The Fmoc-glycine-loaded resin was rinsed with DMF before a solution of piperidine/DMF (10 mL, 1 : 4) was added to the resin and agitated for 10 min. The solution was drained and the procedure was repeated for a further 20 min. The solution was drained off while the remaining resin was washed with DMF (15 mL), isopropanol (15 mL), followed by n-hexane (15 mL). The resin was then extensively dried before storing in the desiccator for 16 h. CH 2 Cl 2 (25 mL) was used to swell the resin, which was then drained, before a solution of Fmoc-DOPA(TBDMS) 2 -OH (2.59 g, 4.00 mmol), HOBt (1.01 g, 7.50 mmol), HATU (2.85 g, 7.50 mmol) and DIPEA (1.74 mL, 10.0 mmol) in DMF (7.50 mL) was added to the resin and shaken for 2 h. The solution was then drained and the resin was washed with DMF (10 mL). A solution of piperidine in DMF (10 mL, 1 : 4) was added to the Fmoc-DOPA (TBDMS) 2 -Gly-loaded resin and agitated. After 10 min, the solution was drained and the procedure was repeated for a further 20 min. The solution was drained and the DOPA (TBDMS) 2 -Gly-loaded resin was washed with DMF (10 mL) before a solution of Fmoc-His(Trt)-OH (3.1 g, 5.0 mmol), HOBt (1.01 g, 7.50 mmol), HATU (2.85 g, 7.50 mmol) and DIPEA (1.74 mL, 10.0 mmol) in DMF (7.50 mL) was added. The mixture was agitated for 90 min before the solution was drained. The Fmoc-His(Trt)-DOPA(TBDMS) 2 -Gly-loaded resin was washed with DMF (15 mL), isopropanol (15 mL), followed by n-hexane (15 mL) and was extensively dried before storing in the desiccator for 16 h. The protected peptide was cleaved from the resin using a solution of 2,2,2-trifluoroethanol in CH 2 Cl 2 (25 mL, 1 : 4) to give the desired product 4 as a yellow solid (1.71 g, 79% (3) . DMF (1 mL) was added to 4 (1.0 g, 0.92 mmol) and HOBt·NH 3 (0.280 g, 1.85 mmol), followed by EDC·HCl (0.18, 0.92 mmol). The solution was stirred at r.t. for 18 h under nitrogen. EtOAc (15 mL) was then added and the mixture washed with water (20 mL) followed by brine (20 mL), dried (MgSO 4 ) and solvent removed in vacuo. Purification by silica gel column chromatography (eluting with n-hexane/EtOAc 1 : 9 to EtOAc) afforded the desired product 3 as a white solid (0.90 g, 90% 
5230).
A mixture of (Z)-but-1-en-3-yne-1,4-diyldibenzene (5) and (E)-but-1-en-3-yne-1,4-diyldibenzene (6) . An oven-dried flask was charged with 3 (51.0 mg, 47.1 µmol), bis(2-methylallyl) (1,5-cyclooctadiene)ruthenium(II) (0.75 mg, 2.36 µmol), 1,4-bis (dicyclohexylphosphino)butane (1.27 mg, 2.83 µmol) and ytterbium triflate (1.17 mg, 1.88 µmol) under an atmosphere of nitrogen. Degassed DMF (0.2 mL) and phenylacetylene (0.01 mL, 94.2 µmol) were added to the flask followed by degassed water (5 µL, 0.28 mmol). The solution was stirred at 60°C for 6 h, then poured into sat. aqueous NaHCO 3 (10 mL). The resulting mixture was extracted with EtOAc (3 × 20 mL), the combined organic layers were then washed with water (10 mL) and brine (10 mL), dried (MgSO 4 ) and the solvent removed in vacuo. Purification by silica gel column chromatography (eluting with n-hexane) gave a mixture of 5 and 6 as an orange oil (7.7 mg, 80%). Data for a mixture of 5 and 6: R f 0.34 (n-hexane); IR (ATR) ν max 3059, 3025, 1596, 1489, 1447, 1263, 1176 cm (9H-Fluoren-9-yl)methyl (Z)-(2-oxo-2-(styrylamino)ethyl) carbamate (10). Fmoc-Gly-NH 2 (9) (0.296 g, 1.00 mmol), bis(2-methylallyl)(1,5-cyclooctadiene)ruthenium(II) (0.016 g, 0.050 mmol), 1,4-bis(dicyclohexylphosphino)butane (0.027 g, 0.060 mmol) and ytterbium triflate (0.025 g, 0.040 mmol) were placed in a two neck flask and the air evacuated. The system was then flushed with nitrogen. Degassed DMF (3 mL), phenylacetylene (0.22 mL, 2.0 mmol) and degassed water (0.108 mL, 6.00 mmol) were added. The mixture was stirred under nitrogen at 60°C for 6 h. The reaction mixture was added into sat. aqueous NaHCO 3 solution (30 mL) and was extracted with EtOAc (4 × 20 mL). The combined organic layers were washed with water (30 mL) and brine (30 mL), dried (MgSO 4 ), filtered, and the solvent removed in vacuo. Purification using silica gel column chromatography (eluting with n-hexane/EtOAc 9 : 1 to n-hexane/EtOAc 7 : 3) gave the desired product 10 as a yellow foam (0.38 g, 96% (12) . Boc-Gly-NH 2 (11) (0.17 g, 1.0 mmol), bis(2-methylallyl)(1,5-cyclooctadiene)ruthenium(II) (0.016 g, 0.050 mmol), 1,4-bis (dicyclohexylphosphino)butane (0.027 g, 0.060 mmol) and ytterbium triflate (0.024 g, 0.040 mmol) were placed under vacuum and then flushed with nitrogen (four times). Subsequently, degassed DMF (3 mL), phenylacetylene (0.22 mL, 2.0 mmol) and degassed water (0.108 mL, 6.00 mmol) were added. The mixture was stirred under nitrogen at 60°C for 6 h, then poured into sat. aqueous NaHCO 3 (30 mL). The resulting mixture was extracted with EtOAc (4 × 20 mL), the combined organic layers were washed with water (30 mL) and brine (30 mL), dried (MgSO 4 ) and the solvent removed in vacuo. Purification by silica gel column (Z)-2-Amino-N-styrylacetamide (8) . A solution of piperidine (0.9 mL, 20% in DMF) was added to 10 (0.086 g, 0.22 mmol) and stirred under nitrogen for 20 min. EtOAc (20 mL) was added and washed with H 2 O (5 mL), the organic layer separated and the solvent removed in vacuo. Purification using silica gel column chromatography (eluting with n-hexane to EtOAc to CH 2 Cl 2 /MeOH 9 : 1) gave the desired product 8 as a yellow oil (0.032 g, 84%).
Alternatively, a solution of TFA/TIS/H 2 O (0.5 mL, 95 : 2.5 : 2.5) was added to 12 (0.042 g, 0.15 mmol) and the solution was stirred at 0°C under nitrogen for 20 min. The reaction was concentrated in vacuo. Purification using silica gel column chromatography (eluting with n-hexane/EtOAc 9 : 1 to EtOAc to CH 2 Cl 2 /MeOH 9 : 1) gave the desired product 8 as a yellow oil (0.021 g, 78%). 
Fmoc-His(Trt)-DOPA(TBDMS) 2 -OH (7)
. A solution of Fmoc-DOPA(TBDMS) 2 -OH 12 (2.00 g, 3.09 mmol) in CH 2 Cl 2 (25 mL) was added to 2-chlorotrityl chloride resin (loading at 0.5 mmol g −1 , 6.18 g), followed by DIPEA (0.54 mL, 3.09 mmol).
After the resin mixture was agitated for 10 min, DIPEA (0.81 mL, 4.63 mmol) was added and the mixture was further shaken for 1 h. The solution was drained off and the resin was washed with DMF (20 mL). A solution of CH 2 Cl 2 /MeOH/DIPEA (40 mL, 80 : 15 : 5) was added to the mixture and shaken for 20 min. The solution was drained and the procedure was repeated. The resin was then washed with DMF (20 mL). Piperidine in DMF (15 mL, 1 : 4) was added to the resin mixture and shaken for 10 min. The liquid was drained off and the piperidine washing was repeated for another 20 min. The amino acid-loaded resin was thoroughly washed with DMF (20 mL), isopropanol (20 mL) and n-hexane (20 mL). The resin was dried under vacuum for 30 min and stored in a desiccator overnight. CH 2 Cl 2 (40 mL) was added to the amino acid-loaded resin which was left to swell for 1 h. The solution was drained and a solution of HBTU (4.39 g, 11.6 mmol), HOBt (1.57 g, 11.6 mmol), Fmoc-His(Trt)-OH (4.79 g, 7.72 mmol) and DIPEA (2.69 mL, 15.4 mmol) in DMF (11.6 mL) was added. The amino acid resin mixture was agitated for 2 h. The solution was then drained and washed with DMF (20 mL), isopropanol (20 mL) and n-hexane (20 mL). The resin was extensively dried and stored in a desiccator overnight. 
4856). (9H-Fluoren-9-yl)methyl((S)-1-(((S)-3-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)-1-oxo-1-((2-oxo-2-(((Z)-styryl)amino)ethyl) amino)propan-2-yl)amino)-1-oxo-3-(1-trityl-1H-imidazol-4-yl)
propan-2-yl)carbamate (13) . To a solution of 7 (74.2 mg, 72.4 μmol), HBTU (54.9 mg, 0.140 mmol) and HOBt (19.6 mg, 0.14 mmol) dissolved in DMF (0.50 mL) was added DIPEA (37.8 µL, 0.22 mmol). The mixture was stirred at r.t. under nitrogen for 1 h before a solution of 8 (12.7 mg, 72.4 µmol) in DMF (0.50 mL) was added. The reaction mixture was stirred at r.t. for 26 h before EtOAc (20 mL) was added and washed with H 2 O (10 mL), 10% aqueous HCl (10 mL), sat. aqueous NaHCO 3 (10 mL) and brine (10 mL). The organic layer was dried (MgSO 4 ), filtered and the solvent removed in vacuo to give a yellow oil. Purification using silica gel chromatography (eluting with n-hexane/EtOAc 8 : 2 to n-hexane/EtOAc 6 : 4) gave the desired product 13 as a yellow foam (30.0 mg, 35% (14) . Piperidine (0.32 mL, 20% in DMF) was added to 13 (0.078 g, 0.066 mmol) and stirred at r.t. under nitrogen atmosphere. After 1 h, the brown solution was added to EtOAc (20 mL) and washed with water (10 mL). The aqueous layer was further washed with EtOAc (2 × 20 mL), the organic layers were combined and dried in vacuo. Purification by silica gel column chromatography (CH 2 Cl 2 /MeOH 9 : 1), afforded the desired product 14 as a yellow oil (59.4 mg, 94%). N-((S)-3-(3,4-dihydroxyphenyl)-1-oxo-1-((2-oxo-2-(((Z)-styryl) amino)ethyl)amino)propan-2-yl)-3-(1-trityl-1H-imidazol-4-yl)propanamide (15) . Compound 14 (54.8 mg, 56.9 μmol) was dissolved in THF (0.50 mL) under nitrogen atmosphere and the resulting yellow solution was stirred in an ice bath. Triethylamine trihydrofluoride (27.8 μL, 0.170 mmol) was then added dropwise to the yellow solution and continued to stir for 45 min. The reaction mixture was dried under a stream of N 2 gas, after which, water (15 mL) was added and the aqueous layer was extracted with CH 2 Cl 2 (4 × 20 mL), the organic layers were combined and solvent was removed in vacuo to give a yellow foam. Purification by silica gel column chromatography (eluting with EtOAc to MeOH/CH 2 Cl 2 , 1 : 9), afforded 15 as a yellow oil (30.5 mg, 73%). (2) . A solution of 0.01 N HCl/HFIP-TIS/H 2 O (1 mL, 95 : 2.5 : 2.5) was added to 15 (35.0 mg, 47.7 µmol) and the solution was stirred at r.t. for 1 h. The solution was then dried under nitrogen and the crude product was purified by C 8 column chromatography (eluting with H 2 O to H 2 O/MeOH 6 : 4) to afford the desired product 2 as a white solid (18.0 mg, 77% (20) . Triethylamine (1.40 mL) was added to a solution of tert-butyl 6-bromo-3-iodo-1H-indole-1-carboxylate (19) (0.59 g, 1.40 mmol) in DMF (1.40 mL) and was degassed in a sonic bath for 30 min, under nitrogen. Bis(triphenylphosphine)palladium(II) dichloride (19.7 mg, 28.1 µmol), copper(I) iodide (10.7 mg, 56.2 µmol) and ethynyltrimethylsilane (174.6 µL, 1.26 mmol) were added to the solution. After the solution was stirred at 60°C for 2 h, it was quenched with water (30 mL) and extracted with EtOAc (3 × 25 mL). The organic layers were combined and dried (MgSO 4 ). The organic solvent was then removed in vacuo. The crude product was passed through a short plug of silica (n-hexane/EtOAc 20 : 1) to afford 20 as a brown oil (0.489 g, 99% yield). R f 0.93 (n-hexane/ tert-Butyl 6-bromo-3-ethynyl-1H-indole-1-carboxylate (17) . tert-Butyl 6-bromo-3-((trimethylsilyl)ethynyl)-1H-indole-1-carboxylate 20 (0.54 g, 1.38 mmol) in THF (30 mL) was stirred in ice bath for 10 min before tetrabutylammonium fluoride (0.44 g, 1.68 mmol) was added and was further stirred in ice bath for 20 min, under nitrogen. Sat. aqueous NH 4 Cl (25 mL) was added and extracted with diethyl ether (4 × 20 mL), dried (MgSO 4 ) and concentrated in vacuo. The crude brown oil was purified by silica gel column chromatography eluting with n-hexane to give 17 as brown solid (0.32 g, 72% yield) (21) and di-tert-butyl 3,3′-(but-1-en-3-yne-1,4-diyl)(E)-bis(6-bromo-1H-indole-1-carboxylate) (22) . FmocGly-NH 2 (9) (0.287 g, 0.97 mmol), tert-butyl 6-bromo-3-ethynyl-1H-indole-1-carboxylate 17 (0.618 g, 1.94 mmol), bis(2-methylallyl)(1,5-cyclooctadiene)ruthenium(II) (15.0 mg, 47.0 µmol), 1,4-bis(dicyclohexylphosphino)butane (26.0 mg, 58.0 µmol) and ytterbium triflate (24.0 mg, 38.7 µmol) were placed under vacuum and then flushed with nitrogen (four times). Subsequently, degassed DMF (3.00 mL) was added, followed by degassed water (105.0 µL, 5.82 mmol) and the mixture was further stirred under nitrogen at 70°C for 24 h. The reaction mixture was added to sat. aqueous NaHCO 3 (30 mL) and the resulting mixture was extracted with EtOAc (5 × 20 mL). The organic layers were combined and washed with water (30 mL) then brine (30 mL), dried (MgSO 4 ), filtered, and the solvent removed in vacuo. Purification using silica gel column chromatography (eluting with n-hexane to n-hexane/EtOAc 9 : 1) gave enyne 22 as a brown oil (37.2 mg, 6% yield) and (eluting with n-hexane/ EtOAc 9 : 1 to EtOAc) 21 as a yellow oil (0.164 g, 43% yield).
tert-Butyl Di-tert-butyl 3,3′-(but-1-en-3-yne-1,4-diyl)(E)-bis(6-bromo-1H-indole-1-carboxylate) (22 
Antibiotic susceptibility testing
The susceptibility of bacterial strains to antibiotics and compounds was determined in microplates using the standard broth dilution method in accordance with the recommendations of the Comité de l'AntibioGramme de la Société Française de Microbiologie (CA-SFM). 21 Briefly, the minimal inhibitory concentrations (MICs) were determined with an inoculum of 10 5 CFU in 200 µL of MH broth containing twofold serial dilutions of each drug. The MIC was defined as the lowest concentration of drug that completely inhibited visible growth after incubation for 18 h at 37°C. To determine all MICs, the measurements were independently repeated at least three times. Minimum inhibitory concentration of positive control: colistin [P. aeruginosa (1 µM), E. coli (2 µM)], streptomycin [P. aeruginosa (21.5 µM), E. coli (21.5 µM), S. aureus (21.5 µM), S. intermedius (10.7 µM) and E. faecalis (21.5 µM)] and chloramphenicol [S. aureus (1.5-3 µM), S. intermedius (3-6 µM) and E. faecalis (1.5-3 µM)].
Marine bacteria susceptibility testing
The antibacterial activity assay was performed on the marine environmental bacterial strains Gram-negative V. harveyi ATCC 14126, V. alginolyticus ATCC 17749 and L. anguillarum ATCC 19264 by the liquid growth inhibition in 96-well microplates. A pre-culture of 5 mL marine broth (MB) was prepared by inoculating a colony of each bacterial strain and was incubated at 30°C with stirring overnight. The concentration of the preculture was assessed by measuring the optical density (OD) at 620 nm and was adjusted by dilution in order to obtain a suspension of 0.03 OD. An aliquot of 200 µL of the bacterial suspension was distributed in each well and 10 µL of a serial dilution in DMSO of the pure compound were added in triplicate. The 96-well microplates were incubated at 30°C overnight with shaking (450 rpm). The optical density of the wells was measured at 620 nm with a microplate reader and the inhibition (IC 50 ) was calculated and plotted versus test concentrations.
Antioxidant testing
Quantitative ORAC assay was run as previously described. 22 The result is expressed as relative Trolox (6-hydroxy-2,5,7,8-tetramethyl chroman-2-carboxylic acid) equivalents.
